Brief: Neovacs: Signia Therapeutics Awarded EUR 1.7 Mln Grant From Bpifrance

Neovacs SA

06/01/2022 07:08

Jan 6 (Reuters) - Neovacs SA  ALNEV.PA :
    * ANNOUNCES THAT SIGNIA THERAPEUTICS, A COMPANY IN WHICH IT
INVESTED IN 2021, HAS BEEN AWARDED A €1.7 MILLION DEEPTECH
DEVELOPMENT GRANT FROM BPIFRANCE

Source text for Eikon:  ID:nACT72593 
Further company coverage:  ALNEV.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))